Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × halofantrine × Clear all

NCT00490061 2017-03-06

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

Phase 2 Terminated

17 enrolled 7 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms